Frederick Chite MB ChB. M.D. FASCO. Fellow ECSACOP

CEO, International Cancer Institute Professor & Academic Lead.-KABU. Physician, Chief Medical Oncologist & Hematologist & PI. Kenya.

[Frederick Chite MB ChB. M.D. FASCO. Fellow ECSACOP @ChiteDoc]

Join us in advancing thoracic malignancies care worldwide and improving survivorship, screening, staging, diagnostics, therapies and research in #lungcancer #cancers #Thoraciccancers @Intercancer @IASLC @myESMO @JCO_ASCO @JCOGO_ASCO @ASCO @JTOonline @CANCERKESHO @AORTIC_AFRICA

[KESHO @CANCERKESHO]

𝐀𝐛𝐬𝐭𝐫𝐚𝐜𝐭 𝐒𝐮𝐛𝐦𝐢𝐬𝐬𝐢𝐨𝐧 𝐃𝐞𝐚𝐝𝐥𝐢𝐧𝐞 𝐄𝐱𝐭𝐞𝐧𝐝𝐞𝐝
You asked. The Scientific Committee listened.

The KICC 2026 abstract submission deadline has been extended to 𝟏𝟐 𝐉𝐮𝐧𝐞 𝟐𝟎𝟐𝟔.
🔗Submit your abstract: https://t.co/Yvx5A2h9N4

#KICC2026

[KESHO @CANCERKESHO]

Deadline approaching: 29 May 2026.

Planning to submit an abstract for KICC 2026? Don’t wait for the last-minute rush.

Share your research, case studies, audits, innovations or practice insights with the region’s oncology community.
🔗 https://t.co/uqmW52oa86

[Frederick Chite MB ChB. M.D. FASCO. Fellow ECSACOP @ChiteDoc]

@NCIKenya @DrEliasMelly Congratulations @DrEliasMelly

[Frederick Chite MB ChB. M.D. FASCO. Fellow ECSACOP @ChiteDoc]

https://t.co/gC2WJi0xef

[Frederick Chite MB ChB. M.D. FASCO. Fellow ECSACOP @ChiteDoc]

@CANCERKESHO @AORTIC_AFRICA @ASCO @myESMO @NCIKenya @KenyaMedics_KMA https://t.co/gC2WJi0xef

[Frederick Chite MB ChB. M.D. FASCO. Fellow ECSACOP @ChiteDoc]

Dear Colleagues,
Welcome to the 9th Kenya International Cancer Conference, under the theme
“Equity, Excellence, and Sustainable Impact in Cancer Care.”
November 19-21st 2026 Mombasa, KE
@CANCERKESHO @AORTIC_AFRICA @ASCO @myESMO @NCIKenya @KenyaMedics_KMA

https://t.co/gC2WJi0xef

[International Cancer Institute @Intercancer]

Only a few days to go! Register for our second joint monthly MDT with the AFROC project this year, on April 9, 2026, from 4 - 5 PM EAT. We have two case presentations by Dr. Marina Planelles and Dr. Leanne Prodehl. @AORTIC_AFRICA @CANCERKESHO 1/2

[International Cancer Institute @Intercancer]

For our 2nd joint monthly MDT with the AFROC project this year, on April 9, 2026, from 4 - 5 PM EAT, we have 2 case presentations by Dr. Marina Planelles & Dr. Leanne Prodehl. Our rich panel of discussants includes Dr. Maria Alsina, Dr. Uzayr Khan, & Prof. Florian Lordick 1/2

[Frederick Chite MB ChB. M.D. FASCO. Fellow ECSACOP @ChiteDoc]

@blair_kizza Congratulations

[International Cancer Institute @Intercancer]

Join us on Monday March 16, 2026, from 4 - 5 pm as we talk about Hodgkin's Lymphoma in our virtual multi-disciplinary Tumor board. Our CEO/PI, Prof. Chite Asirwa, MD, FASCO, (@ChiteDoc ) will lead the discussion in this webinar. 1/2

[International Cancer Institute @Intercancer]

Did you know you can use your cover from @PacisInsurance, M-TIBA, @kenbright_ke, @BritamEA,
@KENYANALLIANCE, @First_Assurance, @sanlam, and @AAR_Insurance to access cancer screening, diagnostic testing, treatment, palliative care, & pain management services at our clinic? 1/2

[International Cancer Institute @Intercancer]

Only one day to go! Our first joint monthly MDT of the year with the AFROC project is on March 5, 2026, from 4 - 5 PM EAT. We have two case presentations by Dr. Gayathri Raveendran and Dr. Laura Predel. @myESMO @ASCO @CANCERKESHO @AORTIC_AFRICA 1/2

[International Cancer Institute @Intercancer]

Only a few days to our first joint monthly MDT of the year with the AFROC project on March 5, 2026, from 4 - 5 PM EAT! We have two case presentations by Dr. Gayathri Raveendran (@ga_ya3) and Dr. Laura Predel. @CANCERKESHO @AORTIC_AFRICA @myESMO @ASCO 1/2

[International Cancer Institute @Intercancer]

We are excited for our first joint monthly MDT of the year with the AFROC project on March 5, 2026, from 4 - 5 PM EAT. We'll have two case presentations by Dr. Gayathri Raveendran and Dr. Laura Predel. @CANCERKESHO @AORTIC_AFRICA @myESMO @ASCO 1/2

[Frederick Chite MB ChB. M.D. FASCO. Fellow ECSACOP @ChiteDoc]

@andrewsuleh true & optimal diagnostics and cancer services.

[JTO & JTO CRR @JTOonline]

Celebrating James Chih-Hsin Yang and his lasting impact on JTO as an Associate Editor since 2010. Thank you! #JTO20

[Frederick Chite MB ChB. M.D. FASCO. Fellow ECSACOP @ChiteDoc]

Palbociclib for Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer | New England Journal of Medicine https://t.co/v7cuziYYKB

NEW SoC ALERT! @Intercancer

[Matt Pavelle 🇺🇸 @mattpavelle]

New in @JAMAInternalMed: Bressman et al. argue clinical AI should be regulated like clinicians, not like devices. This is spot on. AI is not a pacemaker; it doesn't fit the "Software as a Medical Device" mold. It's not static, not narrow, and not a one-time review. It practices medicine.

What the authors propose is licensure: prelicensure validation, supervised clinical pilots, defined scope of practice, continuing competency, discipline boards, malpractice accountability.

I agree with this 100%. And it correctly reframes the entire regulatory conversation. The question isn't "is this a safe device?", it's "is this a competent practitioner?"

https://t.co/rgmtQJoTay

[Frederick Chite MB ChB. M.D. FASCO. Fellow ECSACOP @ChiteDoc]

In our #Precisionmedicine series, Please join @Intercancer as we break down #NGS over the next 7 episodes through our MDTs platform. #NGS #Individualizedcare #CancerResearch #cancertreatment #cancercare #QualityEducation #LMIC #prevention #treatments #CURE #Translational